Logo of jmedgeneJournal of Medical GeneticsVisit this articleSubmit a manuscriptReceive email alertsContact usBMJ
J Med Genet. 2000 Oct; 37(10): 766–770.
PMCID: PMC1757160

Dipeptidyl carboxypeptidase 1 (DCP1) and butyrylcholinesterase (BCHE) gene interactions with the apolipoprotein E ε4 allele as risk factors in Alzheimer's disease and in Parkinson's disease with coexisting Alzheimer pathology


Alzheimer's disease (AD) and Parkinson's disease (PD) are genetically heterogeneous. Dipeptidyl carboxypeptidase 1 (DCP1) and butyrylcholinesterase (BCHE) genes may modify the risk of these disorders. We investigated whether common polymorphisms present in these genes operate as risk factors for AD and PD in Finnish subjects, independently or in concert with the apolipoprotein E ε4 allele (APOE ε4). Eighty late onset sporadic AD patients, 53 PD patients (34 of whom had concomitant AD pathology), and 67 control subjects were genotyped for the insertion (I)/deletion (D) polymorphism of DCP1 and the K variant of BCHE. In logistic regression analysis, the DCP1 *I allele in combination with APOE ε4 significantly increased the risk of AD (OR 30.0, 95% CI 7.3-123.7), compared to subjects carrying neither of the alleles. Similar analysis showed that the risk of AD was significantly increased in subjects carrying both the BCHE wild type (*WT/*WT) genotype and ε4 (OR 9.9, 95% CI 2.9-33.8), compared to those without this BCHE genotype and ε4. Further, the risk of PD with AD pathology was significantly increased for carriers of DCP1 *I and ε4 (OR 8.0, 95% CI 2.1-31.1). We thus conclude that, in Finns, interaction between DCP1 *I and ε4 increases the risk of AD as well as of PD with coexisting Alzheimer pathology, which underlines the importance of the DCP1 I/D polymorphism in the development of Alzheimer neuropathology, whereas the wild type BCHE genotype in combination with ε4 had a combined effect with regard to the risk of AD.

Keywords: Alzheimer's disease; Parkinson's disease; dipeptidyl carboxypeptidase 1; butyrylcholinesterase

Full Text

The Full Text of this article is available as a PDF (137K).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Cruts M, Van Broeckhoven C. Molecular genetics of Alzheimer's disease. Ann Med. 1998 Dec;30(6):560–565. [PubMed]
  • Mizuno Y, Hattori N, Mori H. Genetics of Parkinson's disease. Biomed Pharmacother. 1999 Apr;53(3):109–116. [PubMed]
  • Weisgraber KH, Mahley RW. Human apolipoprotein E: the Alzheimer's disease connection. FASEB J. 1996 Nov;10(13):1485–1494. [PubMed]
  • Mattila PM, Koskela T, Röyttä M, Lehtimäki T, Pirttilä TA, Ilveskoski E, Karhunen P, Rinne JO. Apolipoprotein E epsilon4 allele frequency is increased in Parkinson's disease only with co-existing Alzheimer pathology. Acta Neuropathol. 1998 Oct;96(4):417–420. [PubMed]
  • Bajaj NP, Shaw C, Warner T, RayChaudhuri K. The genetics of Parkinson's disease and parkinsonian syndromes. J Neurol. 1998 Oct;245(10):625–633. [PubMed]
  • Checkoway H, Farin FM, Costa-Mallen P, Kirchner SC, Costa LG. Genetic polymorphisms in Parkinson's disease. Neurotoxicology. 1998 Aug-Oct;19(4-5):635–643. [PubMed]
  • Schächter F, Faure-Delanef L, Guénot F, Rouger H, Froguel P, Lesueur-Ginot L, Cohen D. Genetic associations with human longevity at the APOE and ACE loci. Nat Genet. 1994 Jan;6(1):29–32. [PubMed]
  • Kehoe PG, Russ C, McIlory S, Williams H, Holmans P, Holmes C, Liolitsa D, Vahidassr D, Powell J, McGleenon B, et al. Variation in DCP1, encoding ACE, is associated with susceptibility to Alzheimer disease. Nat Genet. 1999 Jan;21(1):71–72. [PubMed]
  • Mellick GD, Buchanan DD, McCann SJ, Davis DR, Le Couteur DG, Chan D, Johnson AG. The ACE deletion polymorphism is not associated with Parkinson's disease. Eur Neurol. 1999;41(2):103–106. [PubMed]
  • Lehmann DJ, Johnston C, Smith AD. Synergy between the genes for butyrylcholinesterase K variant and apolipoprotein E4 in late-onset confirmed Alzheimer's disease. Hum Mol Genet. 1997 Oct;6(11):1933–1936. [PubMed]
  • Singleton AB, Gibson AM, Edwardson JA, McKeith IG, Morris CM. Butyrylcholinesterase K: an association with dementia with Lewy bodies. Lancet. 1998 Jun 13;351(9118):1818–1818. [PubMed]
  • McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology. 1984 Jul;34(7):939–944. [PubMed]
  • Mirra SS, Heyman A, McKeel D, Sumi SM, Crain BJ, Brownlee LM, Vogel FS, Hughes JP, van Belle G, Berg L. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology. 1991 Apr;41(4):479–486. [PubMed]
  • Odawara M, Matsunuma A, Yamashita K. Mistyping frequency of the angiotensin-converting enzyme gene polymorphism and an improved method for its avoidance. Hum Genet. 1997 Aug;100(2):163–166. [PubMed]
  • Jensen FS, Nielsen LR, Schwartz M. Detection of the plasma cholinesterase K variant by PCR using an amplification-created restriction site. Hum Hered. 1996 Jan-Feb;46(1):26–31. [PubMed]
  • Ilveskoski E, Lehtimäki T, Erkinjuntti T, Koivula T, Karhunen PJ. Rapid apolipoprotein E genotyping from mailed buccal swabs. J Neurosci Methods. 1998 Jan 31;79(1):5–8. [PubMed]
  • Alvarez R, Alvarez V, Lahoz CH, Martínez C, Peña J, Sánchez JM, Guisasola LM, Salas-Puig J, Morís G, Vidal JA, et al. Angiotensin converting enzyme and endothelial nitric oxide synthase DNA polymorphisms and late onset Alzheimer's disease. J Neurol Neurosurg Psychiatry. 1999 Dec;67(6):733–736. [PMC free article] [PubMed]
  • Chapman J, Wang N, Treves TA, Korczyn AD, Bornstein NM. ACE, MTHFR, factor V Leiden, and APOE polymorphisms in patients with vascular and Alzheimer's dementia. Stroke. 1998 Jul;29(7):1401–1404. [PubMed]
  • Scacchi R, De Bernardini L, Mantuano E, Vilardo T, Donini LM, Ruggeri M, Gemma AT, Pascone R, Corbo RM. DNA polymorphisms of apolipoprotein B and angiotensin I-converting enzyme genes and relationships with lipid levels in Italian patients with vascular dementia or Alzheimer's disease. Dement Geriatr Cogn Disord. 1998 Jul-Aug;9(4):186–190. [PubMed]
  • Palumbo B, Cadini D, Nocentini G, Filipponi E, Fravolini ML, Senin U. Angiotensin converting enzyme deletion allele in different kinds of dementia disorders. Neurosci Lett. 1999 May 28;267(2):97–100. [PubMed]
  • Panegyres PK, Mamotte CD, Vasikaran SD, Wilton S, Fabian V, Kakulas BA. Butyrycholinesterase K variant and Alzheimer's disease. J Neurol. 1999 May;246(5):369–370. [PubMed]
  • Wiebusch H, Poirier J, Sévigny P, Schappert K. Further evidence for a synergistic association between APOE epsilon4 and BCHE-K in confirmed Alzheimer's disease. Hum Genet. 1999 Feb;104(2):158–163. [PubMed]
  • Tilley L, Morgan K, Grainger J, Marsters P, Morgan L, Lowe J, Xuereb J, Wischik C, Harrington C, Kalsheker N. Evaluation of polymorphisms in the presenilin-1 gene and the butyrylcholinesterase gene as risk factors in sporadic Alzheimer's disease. Eur J Hum Genet. 1999 Sep;7(6):659–663. [PubMed]
  • Hiltunen M, Mannermaa A, Helisalmi S, Koivisto A, Lehtovirta M, Ryynänen M, Riekkinen P, Sr, Soininen H. Butyrylcholinesterase K variant and apolipoprotein E4 genes do not act in synergy in Finnish late-onset Alzheimer's disease patients. Neurosci Lett. 1998 Jun 26;250(1):69–71. [PubMed]
  • Brindle N, Song Y, Rogaeva E, Premkumar S, Levesque G, Yu G, Ikeda M, Nishimura M, Paterson A, Sorbi S, et al. Analysis of the butyrylcholinesterase gene and nearby chromosome 3 markers in Alzheimer disease. Hum Mol Genet. 1998 May;7(5):933–935. [PubMed]
  • Crawford F, Fallin D, Suo Z, Abdullah L, Gold M, Gauntlett A, Duara R, Mullan M. The butyrylcholinesterase gene is neither independently nor synergistically associated with late-onset AD in clinic- and community-based populations. Neurosci Lett. 1998 Jun 19;249(2-3):115–118. [PubMed]
  • Kehoe PG, Williams H, Holmans P, Wilcock G, Cairns NJ, Neal J, Owen MJ. The butyrylcholinesterase K variant and susceptibility to Alzheimer's disease. J Med Genet. 1998 Dec;35(12):1034–1035. [PMC free article] [PubMed]
  • Russ C, Powell J, Lovestone S, Holmes C. K variant of butyrycholinesterase and late-onset Alzheimer's disease. Lancet. 1998 Mar 21;351(9106):881–881. [PubMed]
  • Singleton AB, Smith G, Gibson AM, Woodward R, Perry RH, Ince PG, Edwardson JA, Morris CM. No association between the K variant of the butyrylcholinesterase gene and pathologically confirmed Alzheimer's disease. Hum Mol Genet. 1998 May;7(5):937–939. [PubMed]
  • Grubber JM, Saunders AM, Crane-Gatherum AR, Scott WK, Martin ER, Haynes CS, Conneally PM, Small GW, Roses AD, Haines JL, et al. Analysis of association between Alzheimer disease and the K variant of butyrylcholinesterase (BCHE-K). Neurosci Lett. 1999 Jul 9;269(2):115–119. [PubMed]
  • Ki CS, Na DL, Kim JW, Kim HJ, Kim DK, Yoon BK. No association between the genes for butyrylcholinesterase K variant and apolipoprotein E4 in late-onset Alzheimer's disease. Am J Med Genet. 1999 Apr 16;88(2):113–115. [PubMed]
  • Sodeyama N, Yamada M, Itoh Y, Otomo E, Suematsu N, Matsushita M. Association between butyrylcholinesterase K variant and the Alzheimer type neuropathological changes in apolipoprotein E epsilon4 carriers older than 75 years. J Neurol Neurosurg Psychiatry. 1999 Nov;67(5):693–694. [PMC free article] [PubMed]
  • Yamamoto Y, Yasuda M, Mori E, Maeda K. Failure to confirm a synergistic effect between the K-variant of the butyrylcholinesterase gene and the epsilon4 allele of the apolipoprotein gene in Japanese patients with Alzheimer's disease. J Neurol Neurosurg Psychiatry. 1999 Jul;67(1):94–96. [PMC free article] [PubMed]
  • Mesulam MM, Geula C. Butyrylcholinesterase reactivity differentiates the amyloid plaques of aging from those of dementia. Ann Neurol. 1994 Nov;36(5):722–727. [PubMed]
  • Guillozet AL, Smiley JF, Mash DC, Mesulam MM. Butyrylcholinesterase in the life cycle of amyloid plaques. Ann Neurol. 1997 Dec;42(6):909–918. [PubMed]

Articles from Journal of Medical Genetics are provided here courtesy of BMJ Group


Save items

Related citations in PubMed

See reviews...See all...

Cited by other articles in PMC

See all...


  • MedGen
    Related information in MedGen
  • PubMed
    PubMed citations for these articles
  • Substance
    PubChem chemical substance records that cite the current articles. These references are taken from those provided on submitted PubChem chemical substance records.

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...